Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Feb;149(2):277-293.
doi: 10.1085/jgp.201611721. Epub 2017 Jan 13.

Calmodulin limits pathogenic Na+ channel persistent current

Affiliations

Calmodulin limits pathogenic Na+ channel persistent current

Haidun Yan et al. J Gen Physiol. 2017 Feb.

Abstract

Increased "persistent" current, caused by delayed inactivation, through voltage-gated Na+ (NaV) channels leads to cardiac arrhythmias or epilepsy. The underlying molecular contributors to these inactivation defects are poorly understood. Here, we show that calmodulin (CaM) binding to multiple sites within NaV channel intracellular C-terminal domains (CTDs) limits persistent Na+ current and accelerates inactivation across the NaV family. Arrhythmia or epilepsy mutations located in NaV1.5 or NaV1.2 channel CTDs, respectively, reduce CaM binding either directly or by interfering with CTD-CTD interchannel interactions. Boosting the availability of CaM, thus shifting its binding equilibrium, restores wild-type (WT)-like inactivation in mutant NaV1.5 and NaV1.2 channels and likewise diminishes the comparatively large persistent Na+ current through WT NaV1.6, whose CTD displays relatively low CaM affinity. In cerebellar Purkinje neurons, in which NaV1.6 promotes a large physiological persistent Na+ current, increased CaM diminishes the persistent Na+ current, suggesting that the endogenous, comparatively weak affinity of NaV1.6 for apoCaM is important for physiological persistent current.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
LQT3 mutations in the IQ domain increase the persistent Na+ current amplitude. (A) Exemplar traces of the pseudo-WT NaV1.5TTX-S and Q1909R (magnified region on the right). Y axis of scale bars represents the percentage of persistent current amplitude normalized to the peak Na+ current. The inset shows I-V plots of peak current amplitude for NaV1.5TTX-S and Q1909R, demonstrating no significant difference in peak current amplitude between NaV1.5TTX-S and Q1909R. (B) Magnified region of exemplar traces showing persistent Na+ current for the LQT3 mutations in the CaM C-lobe–binding site and the L1917K. (C) Quantification of persistent Na+ current (as % peak of current). The white number in each bar indicates the number of cells, n. Data are presented as mean ± SEM. **, P < 0.01.
Figure 2.
Figure 2.
LQT3 mutations in the IQ domain decrease apoCaM binding affinity and show reduced persistent Na+ current after CaM overexpression. (A and B) Exemplar ITC traces for apoCaM and a WT NaV1.5 CTD (A) or a Q1909R NaV1.5 CTD (B). (C) Western blot of CaM from lysates of HEK293T cells expressing NaV1.5TTX-S, NaV β1, and empty vector (−) or CaM (+). (D) Exemplar traces of NaV1.5TTX-S with an additional Q1909R mutation coexpressed with CaM (red) or empty vector (black), showing rescue of the persistent Na+ current. (E) Exemplar traces recorded from cells expressing the pseudo-WT NaV1.5TTX-S coexpressed with CaM (red) or empty vector (black), showing no effect on the persistent Na+ current. (F) Quantification of persistent Na+ current amplitude as a percentage of peak current after overexpression of CaM (red) compared with Con (black; data from Fig. 1 C). Data are presented as mean ± SEM. **, P < 0.01.
Figure 3.
Figure 3.
NaV1.5 CTD–CaM heterodimer interaction is disrupted by the Y1795C LQT3 mutation. (A and B) Proposed interaction between two NaV1.5 CTD–CaM heterodimers and position of Y1795C in one of the NaV1.5 CTDs. The positions of Lys1878 in one NaV1.5 CTD globular domain (sky blue) and Lys1922 in the IQ domain of a second NaV1.5 CTD (green), which are available for cross-linking by DSG, are indicated. (C) Coomassie-blue–stained gel of NaV1.5 CTD and CaM after cross-linking with DSG or buffer control (Con). Molecular weight markers are indicated. (D and F) XMapper display of LC/MS data showing DSG cross-linked peptide 1 for the WT NaV1.5 CTD and CaM (WT) and the Y1795C mutant NaV1.5 CTD and CaM. The intensity score (color code) indicates the number of peptides identified for each pairwise interaction. The position of cross-linking between Lys1878 and Lys1922 is circled and indicated by an arrow. (E) LC/MS data showing the cross-linked peptide. (G) Exemplar traces showing increased persistent Na+ current for the Y1795C and rescue by CaM overexpression. (H) Quantification of persistent Na+ current for the pseudo-WT NaV1.5TTX-S and the Y1795C NaV1.5 mutant with and without CaM overexpression. Data are presented as mean ± SEM. **, P < 0.01.
Figure 4.
Figure 4.
CaM overexpression does not affect channel function for mutants that do not display abnormal interactions with CaM. (A) Exemplar traces showing no increased persistent Na+ current for the D1790G and no change after CaM overexpression. (B) Hyperpolarizing shift in the V1/2 of steady-state inactivation for the D1790G mutant NaV1.5 and absence of an effect by CaM overexpression. Data are presented as mean ± SEM. (C) Exemplar traces showing increased persistent Na+ current for the ΔKPQ mutant and no change after CaM overexpression. (D) Gel filtration profiles of the III-IV linker fusion protein (green), Ca2+/CaM (red), and the mixture of the III-IV linker protein and Ca2+/CaM (black). (E) Gel filtration profiles of the III-IV linker fusion protein (green), apoCaM (red, treated with EGTA), and the mixture of the III-IV linker protein and apoCaM (black). (F) Gel filtration profiles of the III-IV linker fusion protein (green), the NaV1.5 CTD (amino acids 1773–1940) complexed with apoCaM (red), and a mixture of the III-IV linker protein and the NaV1.5 CTD–CaM after the addition of 5 mM Ca2+ (black). Insets show Coomassie blue–stained polyacrylamide gels; lane numbers correspond to the fractions labeled in the chromatograms. Molecular weight markers are indicated.
Figure 5.
Figure 5.
ApoCaM regulates persistent Na+ current in neuronal NaV channels. (A and B) Exemplar traces for NaV1.2TTX-R (WT) and the NaV1.2 mutant R1918H showing increased persistent Na+ current for the R1918H mutant (but not for WT) and rescue by CaM overexpression for the R1918H mutant. (C) Summary data showing rescue by CaM for the NaV1.2 mutants H1853R and R1918H. (D) Summary data showing increased τ of inactivation and rescue by CaM for the NaV1.2 mutants H1853R and R1918H. (E) Exemplar traces for NaV1.6TTX-R (WT) expressed in HEK293T cells showing reduced persistent Na+ current by CaM overexpression. (F) Exemplar traces for NaV1.6TTX-R expressed in cultured cerebellar Purkinje neurons and reduced persistent Na+ current by CaM overexpression. (G) Exemplar traces of total NaV Na+ current in cultured cerebellar Purkinje neuron showing reduction in persistent Na+ current after CaM overexpression. The inset shows GFP-expressing cultured cerebellar Purkinje neuron. Bar, 20 µm. (H) Summary data for NaV1.6 expressed in HEK293T cells or in cultured cerebellar Purkinje neurons or total NaV Na+ current in cultured cerebellar Purkinje neurons. Data are presented as mean ± SEM. *, P < 0.05; **, P < 0.01.

References

    1. An R.H., Wang X.L., Kerem B., Benhorin J., Medina A., Goldmit M., and Kass R.S.. 1998. Novel LQT-3 mutation affects Na+ channel activity through interactions between α- and β1-subunits. Circ. Res. 83:141–146. 10.1161/01.RES.83.2.141 - DOI - PubMed
    1. Antzelevitch C., Nesterenko V., Shryock J.C., Rajamani S., Song Y., and Belardinelli L.. 2014. The role of late I Na in development of cardiac arrhythmias. Handbook Exp. Pharmacol. 221:137–168. 10.1007/978-3-642-41588-3_7 - DOI - PMC - PubMed
    1. Benhorin J., Kalman Y.M., Medina A., Towbin J., Rave-Harel N., Dyer T.D., Blangero J., MacCluer J.W., and Kerem B.S.. 1993. Evidence of genetic heterogeneity in the long QT syndrome. Science. 260:1960–1962. 10.1126/science.8316839 - DOI - PubMed
    1. Benhorin J., Goldmit M., MacCluer J.W., Blangero J., Goffen R., Leibovitch A., Rahat A., Wang Q., Medina A., Towbin J., and Kerem B.. 1998. Identification of a new SCN5A mutation, D1840G, associated with the long QT syndrome. Hum. Mutat. 12:72 10.1002/(SICI)1098-1004(1998)12:1<72::AID-HUMU17>3.0.CO;2-Z - DOI - PubMed
    1. Ben-Johny M., Yang P.S., Niu J., Yang W., Joshi-Mukherjee R., and Yue D.T.. 2014. Conservation of Ca2+/calmodulin regulation across Na and Ca2+ channels. Cell. 157:1657–1670. 10.1016/j.cell.2014.04.035 - DOI - PMC - PubMed

Associated data